Your browser doesn't support javascript.
loading
Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS-Mutant Cancers.
Hammerlindl, Heinz; Ravindran Menon, Dinoop; Hammerlindl, Sabrina; Emran, Abdullah Al; Torrano, Joachim; Sproesser, Katrin; Thakkar, Divya; Xiao, Min; Atkinson, Victoria G; Gabrielli, Brian; Haass, Nikolas K; Herlyn, Meenhard; Krepler, Clemens; Schaider, Helmut.
Afiliação
  • Hammerlindl H; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Ravindran Menon D; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Hammerlindl S; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Emran AA; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Torrano J; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Sproesser K; The Wistar Institute, Philadelphia, Pennsylvania.
  • Thakkar D; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Xiao M; The Wistar Institute, Philadelphia, Pennsylvania.
  • Atkinson VG; Division of Cancer Services, Princess Alexandra Hospital, Brisbane, Australia.
  • Gabrielli B; Mater Medical Research Institute, The University of Queensland, Translational Research Institute, Brisbane, Australia.
  • Haass NK; The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Herlyn M; The Wistar Institute, Philadelphia, Pennsylvania.
  • Krepler C; The Wistar Institute, Philadelphia, Pennsylvania.
  • Schaider H; Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia. h.schaider@uq.edu.au.
Clin Cancer Res ; 24(5): 1090-1102, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29196297

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Aspirina / Proteínas ras / Sorafenibe / Neoplasias Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Aspirina / Proteínas ras / Sorafenibe / Neoplasias Limite: Animals / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos